Genome screening, reporting, and genetic counseling for healthy populations

[1]  Matthew S. Lebo,et al.  Development of a clinical polygenic risk score assay and reporting workflow , 2022, Nature Medicine.

[2]  Carol A. Bocchini,et al.  The Gene Curation Coalition: A global effort to harmonize gene-disease evidence resources , 2022, medRxiv.

[3]  K. Kristiansson,et al.  A Web Portal for Communicating Polygenic Risk Score Results for Health Care Use—The P5 Study , 2021, Frontiers in Genetics.

[4]  Trevor J Pugh,et al.  Implementation of serological and molecular tools to inform COVID-19 patient management: protocol for the GENCOV prospective cohort study , 2021, BMJ Open.

[5]  R. Myers,et al.  A study of elective genome sequencing and pharmacogenetic testing in an unselected population , 2021, Molecular genetics & genomic medicine.

[6]  R. Green,et al.  An international policy on returning genomic research results , 2021, Genome Medicine.

[7]  W. Chung,et al.  ACMG SF v3.0 list for reporting of secondary findings in clinical exome and genome sequencing: a policy statement of the American College of Medical Genetics and Genomics (ACMG) , 2021, Genetics in Medicine.

[8]  Bum Chul Kwon,et al.  Design and user experience testing of a polygenic score report: a qualitative study of prospective users , 2021, BMC Medical Genomics.

[9]  A. Clarke,et al.  Opportunistic genomic screening. Recommendations of the European Society of Human Genetics , 2020, European Journal of Human Genetics.

[10]  S. Seminara,et al.  Evaluating co‐created patient‐facing materials to increase understanding of genetic test results , 2020, Journal of genetic counseling.

[11]  Y. Bombard,et al.  Beyond medically actionable results: an analytical pipeline for decreasing the burden of returning all clinically significant secondary findings , 2020, Human Genetics.

[12]  S. South,et al.  Technical standards for the interpretation and reporting of constitutional copy number variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics (ACMG) and the Clinical Genome Resource (ClinGen) , 2019, Genetics in Medicine.

[13]  C. Wright,et al.  Direct-to-consumer genetic testing , 2019, BMJ.

[14]  C. Lejeune,et al.  Secondary findings from whole-exome/genome sequencing evaluating stakeholder perspectives. A review of the literature. , 2019, European journal of medical genetics.

[15]  D. Bick,et al.  Understanding the present and preparing for the future: Exploring the needs of diagnostic and elective genomic medicine patients , 2019, Journal of genetic counseling.

[16]  J. Lazar,et al.  Genome sequencing in the clinic: the past, present, and future of genomic medicine. , 2018, Physiological genomics.

[17]  Karynne E. Patterson,et al.  Stargazer: a software tool for calling star alleles from next-generation sequencing data using CYP2D6 as a model , 2018, Genetics in Medicine.

[18]  J. R. MacDonald,et al.  A Comprehensive Workflow for Read Depth-Based Identification of Copy-Number Variation from Whole-Genome Sequence Data. , 2018, American journal of human genetics.

[19]  Denis C. Bauer,et al.  Evaluation of computational programs to predict HLA genotypes from genomic sequencing data , 2016, Briefings Bioinform..

[20]  K. Kinoshita,et al.  Construction of full-length Japanese reference panel of class I HLA genes with single-molecule, real-time sequencing , 2018, The Pharmacogenomics Journal.

[21]  M. Niknazar,et al.  Evaluating genetic ancestry and self-reported ethnicity in the context of carrier screening , 2017, BMC Genetics.

[22]  Stephen Yip,et al.  The cost and cost trajectory of whole‐genome analysis guiding treatment of patients with advanced cancers , 2017, Molecular genetics & genomic medicine.

[23]  Matthew S. Lebo,et al.  A curated gene list for reporting results of newborn genomic sequencing , 2017, Genetics in Medicine.

[24]  B. Kirkpatrick,et al.  Ancestry Testing and the Practice of Genetic Counseling , 2017, Journal of Genetic Counseling.

[25]  T. Battelino,et al.  High-risk genotypes HLA-DR3-DQ2/DR3-DQ2 and DR3-DQ2/DR4-DQ8 in co-occurrence of type 1 diabetes and celiac disease , 2016, Autoimmunity.

[26]  R. Green,et al.  Personal Genome Sequencing in Ostensibly Healthy Individuals and the PeopleSeq Consortium , 2016, Journal of personalized medicine.

[27]  R. Green,et al.  Comprehensive red blood cell and platelet antigen prediction from whole genome sequencing: proof of principle , 2015, Transfusion.

[28]  Matthew S. Lebo,et al.  Canadian Open Genetics Repository (COGR): a unified clinical genomics database as a community resource for standardising and sharing genetic interpretations , 2015, Journal of Medical Genetics.

[29]  H. Rehm,et al.  Standards and Guidelines for the Interpretation of Sequence Variants: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology , 2015, Genetics in Medicine.

[30]  Robert C. Green,et al.  A One-Page Summary Report of Genome Sequencing for the Healthy Adult , 2015, Public Health Genomics.

[31]  M. Fung,et al.  Using HLA typing to support patients with cancer. , 2015, Cancer control : journal of the Moffitt Cancer Center.

[32]  Marc S. Williams,et al.  ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing , 2013, Genetics in Medicine.

[33]  Anh-Dao Nguyen,et al.  Clinical Genomic Database , 2013, Proceedings of the National Academy of Sciences.

[34]  E. Thorland,et al.  Towards an evidence‐based process for the clinical interpretation of copy number variation , 2012, Clinical genetics.

[35]  T. Klein,et al.  CPIC: Clinical Pharmacogenetics Implementation Consortium of the Pharmacogenomics Research Network , 2011, Clinical pharmacology and therapeutics.

[36]  Sharon R Grossman,et al.  Integrating common and rare genetic variation in diverse human populations , 2010, Nature.

[37]  David H. Alexander,et al.  Fast model-based estimation of ancestry in unrelated individuals. , 2009, Genome research.

[38]  Russ B. Altman,et al.  PharmGKB: the Pharmacogenetics Knowledge Base , 2002, Nucleic Acids Res..